Company: GRCE
Filing Date: 2025-03-10
Form Type: S-3
Source: 0001140361-25-007769
Chunk: 22

Company: Grace Therapeutics, Inc.
Filing Date: 2025-03-10
Form: S-3
Chunk 22
---
 Jersey 07101-3188.                                                                                                                                                       |

| (14) | The number of shares of Common Stock beneficially owned prior to this offering includes 570,007 shares of Common Stock                                                                                                                         
 underlying warrants owned by this Selling Stockholder. Under the terms of such warrants, the holder may not exercise the warrants to the extent such exercise would cause such holder, together with its affiliates, to beneficially own a     
 number of shares of Common Stock which would exceed 19.99% of the number shares of Common Stock outstanding following such exercise (the “19.99% Ownership Cap”). The securities are directly held by Shore Pharma LLC, an entity held in a    
 trust for the benefit of immediate family members by Vimal Kavuru, the Chair of our board of directors, and may be deemed to be beneficially owned by Vimal Kavuru, as the sole member of Shore Pharma LLC. The address of Shore Pharma LLC is 
 c/o Cerity Partners, P.O. Box 10188 #38984, Newark, New Jersey 07101-3188.                                                                                                                                                                     |

8

TABLE OF CONTENTS

PLAN OF DISTRIBUTION Each of the Selling Stockholders of the Common Stock covered by this prospectus and any of its donees, pledgees, transferees or other successors-in-interest, may, from time to time, sell any or all of such shares on any stock exchange, market or trading facility on which such shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. The Selling Stockholders may use any one or more of the following methods when disposing of shares of Common Stock covered by this prospectus:

| • | distributions to members, partners, stockholders or other equityholders of the selling stockholders; |

| • | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |

| • | block trades in which the broker-dealer will attempt to sell such shares as agent, but may position and resell a portion of the 
 block as principal to facilitate the transaction;                                                                               |

| • | purchases by a broker-dealer as principal and resale by the broker-dealer for its account; |

| • | an exchange distribution in accordance with the rules of the applicable exchange; |

| • | privately negotiated transactions; |

| • | short sales and settlement of short